Axel Bolte Inozyme Pharma, Inc. (INZY) insider trading activity

Axel Bolte is of Inozyme Pharma, Inc.. Currently has a direct ownership of 0 shares of INZY, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2025, when has been sold 423,926 shares (Common Stock) at a price of $4.0 per share, resulting in proceeds of $1,695,704. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Axel Bolte Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2025	SELL Disposition due to a tender of shares in a change of control transaction	$1,695,704 $4.0 p/Share	423,926 Reduced 100.0%	0 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	$154,085 $0.98 p/Share	157,230 Added 27.05%	423,926 Common Stock
Mar 31 2023	BUY Grant, award, or other acquisition	$10,621 $2.21 p/Share	4,806 Added 1.77%	266,696 Common Stock
Sep 30 2022	BUY Grant, award, or other acquisition	$7,558 $2.28 p/Share	3,315 Added 1.25%	261,890 Common Stock
Apr 19 2022	BUY Open market or private purchase	$249,998 $3.69 p/Share	67,750 Added 20.76%	258,575 Common Stock
Jun 24 2021	SELL Open market or private sale	-	66,788 Reduced 25.93%	190,825 Common Stock
Jun 24 2021	BUY Exercise of conversion of derivative security	$65,452 $0.98 p/Share	66,788 Added 20.59%	257,613 Common Stock

Also insider at

ISEE

IVERIC bio, Inc. Healthcare

Director

Axel Bolte

Parsippany, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Value

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

Operation

Value

Type

News

Receive news related to Inozyme Pharma, Inc.

Track Activities on INZY

Account